Martin A Eglitis
age ~70
from San Diego, CA
- Also known as:
-
- Martin Dr Eglitis
- Martin Alexandris Eglitis
- Martins A Eglitis
- Martin A Hoffman
- Eglitis Martin
- Phone and address:
-
5895 Blazing Star Ln, San Diego, CA 92130
8584610250
Martin Eglitis Phones & Addresses
- 5895 Blazing Star Ln, San Diego, CA 92130 • 8584610250
- Newbury Park, CA
- Memphis, TN
- Charlottesville, VA
- 8573 Twin Pointe Cir, Indianapolis, IN 46236 • 3178260939 • 7658260939
- Kensington, MD
Work
-
Company:Blazing star pharma advisorsJan 2012
-
Address:Greater San Diego Area
-
Position:President
Education
-
School / High School:University of Virginia1976 to 1980
Skills
Licensing • Strategic Planning • Business Strategy • Competitive Intelligence • Technology Evaluation • Corporate Partnerships • Decision Analysis • Due Diligence • Team Building • Biotechnology • Drug Discovery • Pharmaceuticals • Pharmaceutical Industry • Lifesciences • Oncology • Drug Development • Partnerships • International Business Development • Immunology • Clinical Development • Neuroscience • Pharmacology • Cell • Biopharmaceuticals • Mergers & Acquisitions • Strategy • Commercialization • Cancer • Neurology • Technology Transfer
Languages
English • Latvian • German • Russian • Spanish
Industries
Pharmaceuticals
Resumes
Senior Biotech / Pharma Business Development Executive
view sourcePosition:
President at Blazing Star Pharma Advisors, Senior Management Advisor at Vybion, Inc.
Location:
Greater San Diego Area
Industry:
Pharmaceuticals
Work:
Blazing Star Pharma Advisors - Greater San Diego Area since Jan 2012
President
Vybion, Inc. since Jan 2012
Senior Management Advisor
Teva Pharmaceuticals May 2008 - Dec 2011
Senior Director
Amgen Aug 2004 - May 2008
Director
Eli Lilly and Co Nov 1998 - Jul 2004
Senior Manager
President
Vybion, Inc. since Jan 2012
Senior Management Advisor
Teva Pharmaceuticals May 2008 - Dec 2011
Senior Director
Amgen Aug 2004 - May 2008
Director
Eli Lilly and Co Nov 1998 - Jul 2004
Senior Manager
Education:
University of Virginia 1976 - 1980
University of Virginia 1973 - 1976
University of Virginia 1973 - 1976
Skills:
Licensing
Strategic Planning
Business Strategy
Competitive Intelligence
Technology Evaluation
Corporate Partnerships
Decision Analysis
Due Diligence
Team Building
Biotechnology
Drug Discovery
Pharmaceuticals
Pharmaceutical Industry
Lifesciences
Oncology
Drug Development
Partnerships
International Business Development
Immunology
Clinical Development
Neuroscience
Pharmacology
Cell
Biopharmaceuticals
Mergers & Acquisitions
Strategy
Commercialization
Cancer
Neurology
Technology Transfer
Strategic Planning
Business Strategy
Competitive Intelligence
Technology Evaluation
Corporate Partnerships
Decision Analysis
Due Diligence
Team Building
Biotechnology
Drug Discovery
Pharmaceuticals
Pharmaceutical Industry
Lifesciences
Oncology
Drug Development
Partnerships
International Business Development
Immunology
Clinical Development
Neuroscience
Pharmacology
Cell
Biopharmaceuticals
Mergers & Acquisitions
Strategy
Commercialization
Cancer
Neurology
Technology Transfer
Languages:
English
Latvian
German
Russian
Spanish
Latvian
German
Russian
Spanish
Us Patents
-
Use Of Marrow-Derived Glial Progenitor Cells As Gene Delivery Vehicles Into The Central Nervous System
view source -
US Patent:7022321, Apr 4, 2006
-
Filed:Apr 11, 2002
-
Appl. No.:10/122703
-
Inventors:Martin A. Eglitis - Indianapolis IN, US
Eva Mezey - Rockville MD, US
Mary Maral Mouradian - Bethesda MD, US -
International Classification:A01N 63/00
A01N 65/00
A61K 48/00 -
US Classification:424 9321, 424 931, 424 932
-
Abstract:The present disclosure relates to a method for introducing a hematopoietic cell into the brain of a mammal, by administering bone marrow-derived progenitor cells into the body of the mammal by intravenous injection. The bone marrow-derived cell is preferably a cell that differentiates into a glial cell. The disclosure also relates to a method for delivery of therapeutic protein molecules into the brain of a mammal, by administering to a mammal an effective amount of bone marrow-derived progenitor cells which contain a gene having a nucleic acid sequence that encodes a functional therapeutic protein. Isolated recombinant cells and a pharmaceutical composition are also provided.
-
Use Of Marrow-Derived Glial Progenitor Cells As Gene Delivery Vehicles Into The Central Nervous System
view source -
US Patent:20060134081, Jun 22, 2006
-
Filed:Jan 25, 2006
-
Appl. No.:11/340322
-
Inventors:Martin Eglitis - Indianapolis IN, US
Eva Mezey - Rockville MD, US
Mary Mouradian - Bethesda MD, US -
International Classification:A61K 48/00
C12N 5/08
C12N 15/867 -
US Classification:424093210, 435456000, 435372000
-
Abstract:The present disclosure relates to a method for introducing a hematopoietic cell into the brain of a mammal, by administering bone marrow-derived progenitor cells into the body of the mammal by intravenous injection. The bone marrow-derived cell is preferably a cell that differentiates into a glial cell. The disclosure also relates to a method for delivery of therapeutic protein molecules into the brain of a mammal, by administering to a mammal an effective amount of bone marrow-derived progenitor cells which contain a gene having a nucleic acid sequence that encodes a functional therapeutic protein. Isolated recombinant cells and a pharmaceutical composition are also provided.
Name / Title
Company / Classification
Phones & Addresses
Director Of Surgery
Biocom
Business Association Medical Doctor's Office · Offices and Clinics of Medical Doctors
Business Association Medical Doctor's Office · Offices and Clinics of Medical Doctors
4510 Executive Dr, San Diego, CA 92121
8584550300
8584550300
Youtube
Get Report for Martin A Eglitis from San Diego, CA, age ~70